327 related articles for article (PubMed ID: 17081648)
1. Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics.
Mannermaa E; Vellonen KS; Urtti A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1136-63. PubMed ID: 17081648
[TBL] [Abstract][Full Text] [Related]
2. Advances in the understanding of retinal drug disposition and the role of blood-ocular barrier transporters.
Jordán J; Ruíz-Moreno JM
Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1181-92. PubMed ID: 23647131
[TBL] [Abstract][Full Text] [Related]
3. Polarity and the development of the outer blood-retinal barrier.
Rizzolo LJ
Histol Histopathol; 1997 Oct; 12(4):1057-67. PubMed ID: 9302567
[TBL] [Abstract][Full Text] [Related]
4. Modeling the drug transport in the anterior segment of the eye.
Avtar R; Tandon D
Eur J Pharm Sci; 2008 Oct; 35(3):175-82. PubMed ID: 18662774
[TBL] [Abstract][Full Text] [Related]
5. Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition.
Zhang T; Xiang CD; Gale D; Carreiro S; Wu EY; Zhang EY
Drug Metab Dispos; 2008 Jul; 36(7):1300-7. PubMed ID: 18411399
[TBL] [Abstract][Full Text] [Related]
6. The role of membrane transporters in drug delivery to brain tumors.
Nies AT
Cancer Lett; 2007 Aug; 254(1):11-29. PubMed ID: 17275180
[TBL] [Abstract][Full Text] [Related]
7. In vitro model of the outer blood-retina barrier.
Steuer H; Jaworski A; Stoll D; Schlosshauer B
Brain Res Brain Res Protoc; 2004 Apr; 13(1):26-36. PubMed ID: 15063838
[TBL] [Abstract][Full Text] [Related]
8. Drug delivery to the posterior segment of the eye.
Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
[TBL] [Abstract][Full Text] [Related]
9. Role of retinal pigment epithelium permeability in drug transfer between posterior eye segment and systemic blood circulation.
Ramsay E; Hagström M; Vellonen KS; Boman S; Toropainen E; Del Amo EM; Kidron H; Urtti A; Ruponen M
Eur J Pharm Biopharm; 2019 Oct; 143():18-23. PubMed ID: 31419586
[TBL] [Abstract][Full Text] [Related]
10. Expression, activity and pharmacokinetic impact of ocular transporters.
Vellonen KS; Hellinen L; Mannermaa E; Ruponen M; Urtti A; Kidron H
Adv Drug Deliv Rev; 2018 Feb; 126():3-22. PubMed ID: 29248478
[TBL] [Abstract][Full Text] [Related]
11. Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.
Ranta VP; Urtti A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1164-81. PubMed ID: 17069929
[TBL] [Abstract][Full Text] [Related]
12. Transport barriers in transscleral drug delivery for retinal diseases.
Kim SH; Lutz RJ; Wang NS; Robinson MR
Ophthalmic Res; 2007; 39(5):244-54. PubMed ID: 17851264
[TBL] [Abstract][Full Text] [Related]
13. The role of blood-ocular barrier transporters in retinal drug disposition: an overview.
Tomi M; Hosoya K
Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1111-24. PubMed ID: 20438316
[TBL] [Abstract][Full Text] [Related]
14. Role of transporters in placental transfer of drugs.
Ganapathy V; Prasad PD
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):381-7. PubMed ID: 15979662
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the RPE transcriptome reveals dynamic changes during the development of the outer blood-retinal barrier.
Rizzolo LJ; Chen X; Weitzman M; Sun R; Zhang H
Mol Vis; 2007 Jul; 13():1259-73. PubMed ID: 17679949
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of a model dipeptide transport across blood-ocular barriers following systemic administration.
Atluri H; Anand BS; Patel J; Mitra AK
Exp Eye Res; 2004 Apr; 78(4):815-22. PubMed ID: 15037116
[TBL] [Abstract][Full Text] [Related]
17. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
Deeken JF; Löscher W
Clin Cancer Res; 2007 Mar; 13(6):1663-74. PubMed ID: 17363519
[TBL] [Abstract][Full Text] [Related]
18. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.
Lee G; Dallas S; Hong M; Bendayan R
Pharmacol Rev; 2001 Dec; 53(4):569-96. PubMed ID: 11734619
[TBL] [Abstract][Full Text] [Related]
19. Cell culture models of the ocular barriers.
Hornof M; Toropainen E; Urtti A
Eur J Pharm Biopharm; 2005 Jul; 60(2):207-25. PubMed ID: 15939234
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of ocular drug penetration.
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Crit Rev Ther Drug Carrier Syst; 1999; 16(1):85-146. PubMed ID: 10099899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
